Life Science Leader1d
Where Are They Now? Teva Pharmaceuticals
Teva Pharmaceuticals "pivot to growth" strategy under CEO Richard Francis aims to use a combination of biosimilars, generics, ...
Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
DelveInsight's 'Follicular Lymphoma Pipeline Insight 2024' report provides comprehensive global coverage of pipeline ...
COX-2 Selective NSAIDs Market Research Report 2025-2030: Cumulative Industry Revenues to Exceed $11.3 Billion by 2030
Expansion into Emerging Markets with High Prevalence of Chronic Inflammatory Conditions Presenting Lucrative Opportunities ...
Optimistic Outlook on Doximity: Benefiting from Shifts in Pharmaceutical Advertising and Strong Growth Potential
In a report released today, Glen Santangelo from Jefferies maintained a Buy rating on Doximity (DOCS – Research Report), with a price target of ...
Yahoo Finance3d
Skeletal Dysplasia Treatment Market Analysis by Type, End User, Region and Company - Forecast to 2030
Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Skeletal Dysplasia Market by Type, Treatment, End User - Global Forecast ...
Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference
To access a live webcast of the presentation, visit Teva’s Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations. An archived version of the webcast will be available within ...